Chemomab Therapeutics Ltd Adr (CMMB)

Chemomab Therapeutics Ltd Adr Azioni (CMMB) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	4.71% 9.049	8.642	8.317	6.254	5.32
Income/Loss From Continuing Operations Before Tax	5.69% -8.732	-8.262	-8.08	-6.734	-5.104
Income Tax Expense/Benefit	110.00% 0.021	0.01	-	-0.544	-
Income/Loss From Continuing Operations After Tax	5.81% -8.753	-8.272	-8.08	-6.19	-5.104
Net Income/Loss	5.81% -8.753	-8.272	-8.08	-6.19	-5.104
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	29,185% 221.00	-0.7598	228.77	228.17	-0.041
Diluted Average Shares	29,185% 221.00	-0.7598	228.77	228.17	-0.041
Basic Earnings Per Share	11.11% 0.04	0.036	0.035	0.027	0.023
Diluted Earnings Per Share	11.11% 0.04	0.036	0.035	0.027	0.023
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-